TAM
IMRX icon

Tucker Asset Management’s Immuneering IMRX Stock Holding History

Tucker Asset Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,036
Closed -$112K – 1474
2023
Q2 		$112K Buy
+11,036
New +$106K 0.03% 159

Other funds holding IMRX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Tucker Asset Management's IMRX Position: Q3 2023 in Review

Tucker Asset Management sold out of Immuneering (IMRX) in Q3 2023, closing a stake of 11,036 shares — an estimated $112K sold.

Tucker Asset Management first reported a position in IMRX in Q2 2023 and held it in 1 quarter. The position peaked at $112K in Q2 2023. 52 funds tracked by Wall St. Rank hold IMRX as of Q3 2023.

  • Tucker Asset Management reported no remaining Immuneering position as of Q3 2023 after selling out during the quarter.
  • Tucker Asset Management sold 11,036 Immuneering shares in Q3 2023, an estimated $112K.
  • Tucker Asset Management first reported a position in Immuneering in Q2 2023 and held it in 1 quarter.
  • Tucker Asset Management's Immuneering position peaked at $112K in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Immuneering as of Q3 2023.

Based on Tucker Asset Management's 13F filing for Q3 2023, filed 4 Dec 2023.